BioVie Inc. (BIVI) said that it has priced its underwritten public offering of 2.50 million shares of its Class A common stock at a public offering price of $8.00 per share, for gross proceeds of $20 million, before deducting underwriting discounts, commissions and offering expenses.
In addition, the company has granted the underwriters a 45 day option to purchase up to an additional 375,000 shares of common stock to cover over-allotments at the offering price, less the underwriting discount.
The company plans to use the net proceeds from the offering primarily for general corporate purposes.
For comments and feedback contact: editorial@rttnews.com
Business News
September 11, 2026 16:26 ET Consumer prices data was the main news on the economic front in the U.S. this week. In Europe, the latest interest rate decision from the European Central Bank was the focus along with the revised second quarter economic growth data for the euro area. In Asia, the monthly foreign trade data from China drew attention.